Tonix Pharma (TNXP) says plans advancing to construct commercial-scale manufacturing facility to develop and manufacture vaccines in Bitterroot Valley

Go back to Tonix Pharma (TNXP) says plans advancing to construct commercial-scale manufacturing facility to develop and manufacture vaccines in Bitterroot Valley

Form 8-K Tonix Pharmaceuticals For: Jun 24

June 24, 2021 4:08 PM EDT

yesw

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

... More